Inhibitors of the renin-angiotensin system ameliorates clinical and pathological aspects of experimentally induced nephrotoxic serum nephritis

Introduction: Chronic kidney disease (CKD) is a global health concern, but the current treatments only slow down the progression. Thus an improved understanding of the pathogenesis and novel treatments of CKD are needed. The nephrotoxic nephritis (NTN) model has the potential to study the pathogenes...

Full description

Bibliographic Details
Main Authors: M. E. Ougaard, H. E. Jensen, I. D. Thuen, E. G. Petersen, P. H. Kvist
Format: Article
Language:English
Published: Taylor & Francis Group 2018-10-01
Series:Renal Failure
Subjects:
Online Access:http://dx.doi.org/10.1080/0886022X.2018.1533867
id doaj-701acb5708c44b139971b36d0df7cd86
record_format Article
spelling doaj-701acb5708c44b139971b36d0df7cd862020-11-25T01:46:26ZengTaylor & Francis GroupRenal Failure0886-022X1525-60492018-10-0140164064810.1080/0886022X.2018.15338671533867Inhibitors of the renin-angiotensin system ameliorates clinical and pathological aspects of experimentally induced nephrotoxic serum nephritisM. E. Ougaard0H. E. Jensen1I. D. Thuen2E. G. Petersen3P. H. Kvist4Novo NordiskUniversity of CopenhagenUniversity of CopenhagenUniversity of CopenhagenNovo NordiskIntroduction: Chronic kidney disease (CKD) is a global health concern, but the current treatments only slow down the progression. Thus an improved understanding of the pathogenesis and novel treatments of CKD are needed. The nephrotoxic nephritis (NTN) model has the potential to study the pathogenesis of CKD as it resembles human CKD. The classical treatments with angiotensin II receptor blocker (ARB) or the angiotensin-converting enzyme inhibitor (ACE I) have shown a clinical effect in CKD. Methods: We characterized the disease development in the NTN model over 11 weeks by investigating functional and histopathological changes. We tested doses of 15 and 30 mg/kg/day enalapril and losartan in the NTN model in order to investigate the effect of inhibiting the renin-angiotensin-system (RAS). Results: The NTN model displayed albuminuria peaking on days 6–7, mesangial expansion (ME), renal fibrosis, inflammation and iron accumulation peaking on day 42. However, albuminuria, ME, renal fibrosis and inflammation were still significantly present on day 77, suggesting that the NTN model is useful for studying both the acute and chronic disease phases. Enalapril and losartan significantly enhanced the glomerular filtration rate (GFR) and decreased albuminuria, ME, renal fibrosis and inflammation of NTN-induced kidney disease in mice. Conclusions: This is the first study showing a comprehensive pathological description of the chronic features of the murine NTN model and that inhibiting the RAS pathway show a significant effect on functional and morphological parameters.http://dx.doi.org/10.1080/0886022X.2018.1533867Nephrotoxic serum nephritispathologyangiotensin-converting enzyme inhibitorangiotensin II receptor blocker
collection DOAJ
language English
format Article
sources DOAJ
author M. E. Ougaard
H. E. Jensen
I. D. Thuen
E. G. Petersen
P. H. Kvist
spellingShingle M. E. Ougaard
H. E. Jensen
I. D. Thuen
E. G. Petersen
P. H. Kvist
Inhibitors of the renin-angiotensin system ameliorates clinical and pathological aspects of experimentally induced nephrotoxic serum nephritis
Renal Failure
Nephrotoxic serum nephritis
pathology
angiotensin-converting enzyme inhibitor
angiotensin II receptor blocker
author_facet M. E. Ougaard
H. E. Jensen
I. D. Thuen
E. G. Petersen
P. H. Kvist
author_sort M. E. Ougaard
title Inhibitors of the renin-angiotensin system ameliorates clinical and pathological aspects of experimentally induced nephrotoxic serum nephritis
title_short Inhibitors of the renin-angiotensin system ameliorates clinical and pathological aspects of experimentally induced nephrotoxic serum nephritis
title_full Inhibitors of the renin-angiotensin system ameliorates clinical and pathological aspects of experimentally induced nephrotoxic serum nephritis
title_fullStr Inhibitors of the renin-angiotensin system ameliorates clinical and pathological aspects of experimentally induced nephrotoxic serum nephritis
title_full_unstemmed Inhibitors of the renin-angiotensin system ameliorates clinical and pathological aspects of experimentally induced nephrotoxic serum nephritis
title_sort inhibitors of the renin-angiotensin system ameliorates clinical and pathological aspects of experimentally induced nephrotoxic serum nephritis
publisher Taylor & Francis Group
series Renal Failure
issn 0886-022X
1525-6049
publishDate 2018-10-01
description Introduction: Chronic kidney disease (CKD) is a global health concern, but the current treatments only slow down the progression. Thus an improved understanding of the pathogenesis and novel treatments of CKD are needed. The nephrotoxic nephritis (NTN) model has the potential to study the pathogenesis of CKD as it resembles human CKD. The classical treatments with angiotensin II receptor blocker (ARB) or the angiotensin-converting enzyme inhibitor (ACE I) have shown a clinical effect in CKD. Methods: We characterized the disease development in the NTN model over 11 weeks by investigating functional and histopathological changes. We tested doses of 15 and 30 mg/kg/day enalapril and losartan in the NTN model in order to investigate the effect of inhibiting the renin-angiotensin-system (RAS). Results: The NTN model displayed albuminuria peaking on days 6–7, mesangial expansion (ME), renal fibrosis, inflammation and iron accumulation peaking on day 42. However, albuminuria, ME, renal fibrosis and inflammation were still significantly present on day 77, suggesting that the NTN model is useful for studying both the acute and chronic disease phases. Enalapril and losartan significantly enhanced the glomerular filtration rate (GFR) and decreased albuminuria, ME, renal fibrosis and inflammation of NTN-induced kidney disease in mice. Conclusions: This is the first study showing a comprehensive pathological description of the chronic features of the murine NTN model and that inhibiting the RAS pathway show a significant effect on functional and morphological parameters.
topic Nephrotoxic serum nephritis
pathology
angiotensin-converting enzyme inhibitor
angiotensin II receptor blocker
url http://dx.doi.org/10.1080/0886022X.2018.1533867
work_keys_str_mv AT meougaard inhibitorsofthereninangiotensinsystemamelioratesclinicalandpathologicalaspectsofexperimentallyinducednephrotoxicserumnephritis
AT hejensen inhibitorsofthereninangiotensinsystemamelioratesclinicalandpathologicalaspectsofexperimentallyinducednephrotoxicserumnephritis
AT idthuen inhibitorsofthereninangiotensinsystemamelioratesclinicalandpathologicalaspectsofexperimentallyinducednephrotoxicserumnephritis
AT egpetersen inhibitorsofthereninangiotensinsystemamelioratesclinicalandpathologicalaspectsofexperimentallyinducednephrotoxicserumnephritis
AT phkvist inhibitorsofthereninangiotensinsystemamelioratesclinicalandpathologicalaspectsofexperimentallyinducednephrotoxicserumnephritis
_version_ 1725019586605088768